Skip to content

Clinical trials

Expanded access Melanoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Phase: Expanded access Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available16
Available5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Bristol-Myers Squibb2
Novartis Pharmaceuticals2
Agenus Inc.1
Biogen1
Center Trials & Treatment1
Delcath Systems Inc.1
Eli Lilly and Company1
Fred Hutchinson Cancer Center1
Genexine, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma21
Carcinoma, Non-Small-Cell Lung3
Colorectal Neoplasms3
Glioblastoma3
Ovarian Neoplasms3
Pancreatic Neoplasms3
Carcinoma, Hepatocellular2
Glioma2
Prostatic Neoplasms2
Uveal Melanoma2

Trials

Showing 76 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.